Lifecore Biomedical Inc
NASDAQ:LFCR
Net Margin
Lifecore Biomedical Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
Lifecore Biomedical Inc
NASDAQ:LFCR
|
243m USD |
-13%
|
|
| JP |
G
|
Goyo Foods Industry Co Ltd
TSE:2230
|
53.2T JPY |
4%
|
|
| CH |
|
Nestle SA
SIX:NESN
|
231.6B CHF |
12%
|
|
| US |
|
Mondelez International Inc
NASDAQ:MDLZ
|
84B USD |
13%
|
|
| FR |
|
Danone SA
PAR:BN
|
46B EUR |
7%
|
|
| ZA |
T
|
Tiger Brands Ltd
JSE:TBS
|
41.2B Zac |
8%
|
|
| US |
|
Kraft Heinz Co
NASDAQ:KHC
|
35.7B USD |
11%
|
|
| US |
|
Hershey Co
NYSE:HSY
|
33.6B USD |
20%
|
|
| US |
|
General Mills Inc
NYSE:GIS
|
32.6B USD |
13%
|
|
| CN |
|
Foshan Haitian Flavouring and Food Co Ltd
SSE:603288
|
229.9B CNY |
23%
|
|
| CH |
|
Chocoladefabriken Lindt & Spruengli AG
SIX:LISN
|
26.3B CHF |
12%
|
Lifecore Biomedical Inc
Glance View
Lifecore Biomedical, Inc. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. The company is headquartered in Chaska, Minnesota and currently employs 689 full-time employees. The firm offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials, as well as the manufacture of pharmaceutical-grade Hyaluronic Acid. The company provides complete CDMO services for injectable pharmaceuticals and medical devices. The Company’s services include sodium hyaluronate, development, manufacturing, and analytical services. The company offers a range of average molecular weights and custom modifications for research and development (R&D), clinical, and commercial applications. The Company’s therapeutic applications include drug delivery, biomaterials, ophthalmology, orthopedics, aesthetics, oncology, and pain management. Its development capabilities include formulation, sterile filtration, filling, packaging, testing, and secondary sterilization.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Lifecore Biomedical Inc's most recent financial statements, the company has Net Margin of -12.5%.
You don't have any saved screeners yet